Venture Capital Investors

Eyenuk

VC investing group Eyenuk provides capital to innovative tech ventures.

Venture Investor Overview

Contact Information

Background Information

Overview

Eyenuk, Inc., is a global artificial intelligence (AI) medical technology company and the leader in real-world AI Eye Screening� for autonomous disease detection and AI Predictive Biomarkers� for risk assessment and disease surveillance. Harnessing the power of AI to analyze retinal images was the inspiration of Eyenuk Founder & CEO Kaushal Solanki. During his own health scare, Solanki faced a four-month long wait to see a specialist about his retinal scans. His own father's struggle with diabetes led Solanki to better understand the risks of diabetic retinopathy, as well as the shortage of qualified professionals to address the issue.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/17/2022

Transaction History

Our records indicate that Eyenuk invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

VP - Engineering

Sandeep Bhat

        

President

Frank Cheng

        

VP - R&D

Chaithanya Ramachandra

        

Chief Executive Officer

Kaushal Solanki

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Eyenuk has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Exxeta Ventures | Eyes of Texas Partners

Share this article

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary